In the skeletal muscle of diabetic mice, STX4 mRNA levels are significantly reduced (93), suggesting that STX4 deficiency may be important for diabetes development, and that re-expression of STX4 may be a therapeutic strategy to restore insulin sensitivity and reverse T2D. The gene discussed is STX4; the disease is diabetes mellitus.